On the other hand, TIMP-1, the primary endogenous inhibitor of MMP-9, has a protective effect on AAA formation, suggested by the finding that TIMP-1-deficient mice developed larger aneurysms after elastase infusion compared to wild-type mice [76]. Here, MMP9 is linked to triple-A syndrome.